Biogen filed reports with the SEC regarding holdings, while institutional investors increased stock holdings and analyst reports influenced market perception.
2 reports, 2 independent
Updated Aug 2
Gone quiet
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Biogen filed reports with the SEC regarding holdings, while institutional investors increased stock holdings and analyst reports influenced market perception.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
Related events
- Institutional investors filed reports with the SEC concerning Carter's.
- Regeneron Pharmaceuticals filed required reports with the SEC regarding institutional holdings on September 8, 2026.
- Insider trading and institutional ownership changes related to Madrigal Pharmaceuticals were disclosed to the SEC.
- Bristol Myers Squibb filed with the SEC on May 28, 2026, regarding increased institutional ownership and share purchases.
- Moderna stock activity, including institutional purchases and analyst ratings, was disclosed to the SEC.